Silexion Therapeutics to Showcase Innovations at Investment Conference
![Silexion Therapeutics to Showcase Innovations at Investment Conference](https://investorshangout.com/images/blog/ihnews-Silexion%20Therapeutics%20to%20Showcase%20Innovations%20at%20Investment%20Conference.jpg)
Silexion Therapeutics to Attend Global Investment Conference
Silexion Therapeutics Corp. (“Silexion” or the “Company”) is preparing to make waves at the H.C. Wainwright 26th Annual Global Investment Conference. This event is an important platform for showcasing innovative technologies and forging connections within the investment community.
Overview of the Conference
The conference will occur from September 9-11 at the renowned Lotte New York Palace Hotel. This gathering of industry leaders and investors presents an exceptional opportunity for Silexion to highlight its groundbreaking work in the oncology sector.
Details of the Presentation
During the conference, Silexion's management will deliver insightful presentations outlining the company's advancements and future directions in cancer treatment. A recorded version of this presentation will be accessible on demand as of September 9, 2024, at 7:00 AM ET.
One-on-One Meetings
Investors interested in engaging more deeply will have the chance for one-on-one meetings with Silexion's management. Those wishing to set up a meeting are encouraged to reach out through their contact at H.C. Wainwright.
About Silexion Therapeutics
Silexion is not just another biotech firm; it’s at the forefront of fighting solid tumor cancers related to the mutated KRAS oncogene. This gene is notably known as a significant driver in various human cancers. The company’s commitment to innovation is evident in its Phase 2a clinical trial results, showcasing promising trends against conventional chemotherapy treatments.
Future Directions in Oncology
The core focus for Silexion is the continued development of its lead product candidate aimed at treating locally advanced pancreatic cancer. Their dedication to pushing boundaries within oncology reflects a broader aim to deliver significant benefits to patients facing serious health challenges.
Contact Information
Silexion Therapeutics Corp
Ms. Mirit Horenshtein Hadar, CFO
mirit@silexion.com
Investors
Chuck Padala
LifeSci Advisors
Chuck@lifesciadvisors.com
Frequently Asked Questions
What is Silexion Therapeutics known for?
Silexion Therapeutics is an innovative biotechnology company focused on developing treatments for solid tumor cancers due to mutated KRAS oncogene.
Where will the conference be held?
The H.C. Wainwright 26th Annual Global Investment Conference will take place at the Lotte New York Palace Hotel.
How can investors meet with Silexion's management?
Investors can arrange one-on-one meetings by contacting their representative at H.C. Wainwright.
When will the presentation be available?
The company presentation will be available on demand starting September 9, 2024, at 7:00 AM ET.
Who should be contacted for further information?
For inquiries, individuals can reach out to Mirit Horenshtein Hadar, the CFO of Silexion Therapeutics Corp, via email.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- AI Video Generator Market Expected to Hit USD 2980 Million
- Bird Construction to Host Investor Day, Unveils Strategic Plan
- Cipher Mining Reports Robust August 2024 Operational Results
- NCL Corporation Ltd. Prices $315 Million Senior Notes Offering
- Franklin Resources, Inc. Investigation by Pomerantz Law Firm
- Investigation Launched for WEBTOON Entertainment Investors
- Investigation of iLearningEngines, Inc. Over Securities Issues
- Investigation into Bumble Inc. by Pomerantz Law Firm - BMBL
- Ibotta Inc. Under Investigation for Alleged Securities Fraud
- Investigation Launched into WisdomTree, Inc. - WT Investors
- Pomerantz Law Firm Investigates Liquidia Corporation Investors
- Investigation into Bank of Montreal by Pomerantz Law Firm
- Investigation into Piedmont Lithium Inc. by Pomerantz Law Firm
- Impact of Fed's Rate Cut on RBA: Insights from Citi Economics
- Investigation Alert: Globus Medical, Inc. (NYSE: GMED) Claims
- Zscaler Reports Growth Yet Stock Drops 13% on Outlook
- Credit Rating Agencies Agree to Settle for $49 Million in Penalties
- Russian Stocks Face Decline as Market Conditions Shift
- Investigation Into Claims Against European Wax Center, Inc. EWCZ
- Investigation Into Mineralys Therapeutics, Inc. (MLYS) Claims
- 36Kr Holdings Inc. Earnings Report: Strategies for Growth Ahead
- Investigation Launched into Mynaric AG by Pomerantz Law Firm
- Colombia Stock Market Update: COLCAP Declines Amid Sector Losses
- Mexican Stock Market Experiences Significant Decline Today
- US Stock Market Faces Volatility as September Begins
Recent Articles
- Russian Stocks Face Decline as Market Conditions Shift
- Levulinic Acid Market Forecast: Growth to $208.52 Million
- US Outdoor Landscape Lighting Market Growth Insights and Trends
- Healthcare Testing, Inspection, and Certification Market Growth
- QIAGEN N.V. Sets Conversion Price for New Convertible Bonds
- ADLM Enhances Patient Care Through New Lipid Testing Guidelines
- Con Edison to Engage Investors at Upcoming Financial Conferences
- Corvus Pharmaceuticals to Showcase Innovations at Investment Event
- Citymark Capital Welcomes Michael McRoberts to Advisory Board
- Nvidia Stock's Recent Struggles: An Investor's Perspective
- Biochar Machine Market Growth Driven by Agricultural Demand
- Intel Faces Dow Jones Removal Amidst Plummeting Shares
- Massive Bitcoin Whale Acquires $19 Million in BTC Holdings
- Riot Games and 1,000 Dreams Fund Empower Women in Esports
- First Citizens Bank Secures $145 Million Financing for Linea Energy
- Unlocking Home Equity: A Pathway to Financial Growth
- Explore Top Dividend Stocks to Consider Investing In
- Stewart Investors Showcases Innovators in Sustainable Food Systems
- Highly Visible Packaging Market Growth Forecast to 2032
- 2024 Control Tower Technology Value Matrix Insights Unveiled
- Tilray Brands Strengthens Craft Beer Portfolio with Acquisition
- Status of Audit for Aktsiaselts Silvano Fashion Group Revealed
- Ethical AI Transformation: The P&C Insurance Industry's Role
- HomeSafe Alliance Achieves Milestone Of 100 Military Moves
- Cleartide Unveils Stylish and Efficient Condensate Pumps